1. Home
  2. AWX vs SNGX Comparison

AWX vs SNGX Comparison

Compare AWX & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWX

Avalon Holdings Corporation

HOLD

Current Price

$2.48

Market Cap

10.3M

Sector

Utilities

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.40

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWX
SNGX
Founded
1998
1987
Country
United States
United States
Employees
N/A
14
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
5.9M
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
AWX
SNGX
Price
$2.48
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
4.2K
10.2M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
$53,090,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$2.40
$0.28
52 Week High
$5.43
$6.23

Technical Indicators

Market Signals
Indicator
AWX
SNGX
Relative Strength Index (RSI) 39.55 39.82
Support Level N/A $0.28
Resistance Level $2.64 $0.41
Average True Range (ATR) 0.08 0.05
MACD -0.01 -0.01
Stochastic Oscillator 0.00 0.56

Price Performance

Historical Comparison
AWX
SNGX

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: